Operating Income (Loss) in USD of Caris Life Sciences, Inc. from Q2 2024 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Caris Life Sciences, Inc. quarterly Operating Income (Loss) history and change rate from Q2 2024 to Q3 2025.
Caris Life Sciences, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $32,642,000.
Source SEC data: View on sec.gov

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Change (%)

Caris Life Sciences, Inc. Quarterly Operating Income (Loss) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025		$32,642,000	+$93,484,000		01 Jul 2025	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025		$-17,989,000	+$49,022,000	+73.2%	01 Apr 2025	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q3 2024		$-60,842,000			01 Jul 2024	30 Sep 2024	10-Q	05 Nov 2025	2025	Q3
Q2 2024		$-67,011,000			01 Apr 2024	30 Jun 2024	10-Q	12 Aug 2025	2025	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.